An SNRI (serotonin and norepinephrine reuptake inhibitor) is one of two major classes of medications used to treat clinical ...
233,003 bottles of duloxetine have been recalled due to potentially containing high levels of cancer-causing impurities.
Fact checked by Nick Blackmer Certain bottles and doses of duloxetine, a common antidepressant, have been recalled due to the ...
More than 233,000 bottles of an antidepressant have been recalled by the FDA due to the presence of duloxetine posing the risk of cancer.
The bottles were distributed nationwide, including in Wisconsin, and received the FDA's second-most severe risk ...
Duloxetine is an antidepressant, with a specific batch having been recalled due to the presence of potentially cancer-causing ...
In three separate reports, the FDA said that various doses of duloxetine delayed-release capsules were recalled due to the ...
A New Jersey pharmaceutical company is recalling more than 230,000 bottles of duloxetine antidepressants after detecting a ...
The Food and Drug Administration has recalled Duloxetine, a commonly prescribed antidepressant, due to fears it could contain ...
The recommended dosage of duloxetine is 40 80 mg daily, depending on the indication, preferably split into two doses per day. For the treatment of major depression, duloxetine has achieved ...